KLP Kapitalforvaltning AS Buys New Shares in Maximus, Inc. (NYSE:MMS)

KLP Kapitalforvaltning AS purchased a new position in shares of Maximus, Inc. (NYSE:MMS) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 24,400 shares of the health services provider’s stock, valued at approximately $1,821,000.

A number of other hedge funds also recently made changes to their positions in the stock. Reinhart Partners LLC. raised its position in shares of Maximus by 43.5% in the 4th quarter. Reinhart Partners LLC. now owns 551,146 shares of the health services provider’s stock worth $41,143,000 after buying an additional 167,019 shares during the period. Sio Capital Management LLC acquired a new stake in Maximus during the third quarter worth about $14,453,000. Ruffer LLP purchased a new position in shares of Maximus in the 4th quarter worth about $10,266,000. Barclays PLC lifted its stake in shares of Maximus by 285.1% in the 3rd quarter. Barclays PLC now owns 170,971 shares of the health services provider’s stock valued at $15,927,000 after purchasing an additional 126,573 shares in the last quarter. Finally, Empowered Funds LLC purchased a new stake in shares of Maximus during the 4th quarter worth about $8,139,000. Institutional investors and hedge funds own 97.21% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Raymond James raised shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target on the stock in a research report on Thursday, January 2nd. StockNews.com downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th.

Insider Buying and Selling at Maximus

In related news, insider Ilene R. Baylinson sold 14,500 shares of the company’s stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the sale, the insider now directly owns 2,512 shares of the company’s stock, valued at approximately $171,167.68. This represents a 85.23 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Jan Madsen sold 2,439 shares of the stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now directly owns 18,097 shares in the company, valued at $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.

Maximus Price Performance

Shares of NYSE MMS opened at $68.06 on Friday. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97. The company has a market capitalization of $3.85 billion, a price-to-earnings ratio of 14.64 and a beta of 0.71. The business has a 50-day moving average of $70.21 and a 200-day moving average of $78.02.

Maximus (NYSE:MMS) last issued its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. On average, equities analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were issued a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 1.76%. Maximus’s dividend payout ratio is presently 25.81%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.